share_log

Investors in Intuitive Surgical (NASDAQ:ISRG) Have Seen Splendid Returns of 117% Over the Past Five Years

Investors in Intuitive Surgical (NASDAQ:ISRG) Have Seen Splendid Returns of 117% Over the Past Five Years

Intuitive Surgical(納斯達克股票代碼:ISRG)的投資者在過去五年中獲得了117%的豐厚回報
Simply Wall St ·  02/09 06:05

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if you buy shares in a high quality company at the right price, you can gain well over 100%. For example, the Intuitive Surgical, Inc. (NASDAQ:ISRG) share price has soared 117% in the last half decade. Most would be very happy with that. It's also good to see the share price up 39% over the last quarter. The company reported its financial results recently; you can catch up on the latest numbers by reading our company report.

任何股票(假設你不使用槓桿)的最大損失是你的資金的100%。但好的一面是,如果你以合適的價格購買一家高質量公司的股票,你可以獲得超過100%的收益。例如,Intuitive Surgical, Inc.(納斯達克股票代碼:ISRG)的股價在過去五年中飆升了117%。大多數人會對此感到非常滿意。股價在上個季度上漲了39%也是件好事。該公司最近公佈了財務業績;您可以通過閱讀我們的公司報告來了解最新的數字。

So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.

因此,讓我們調查一下,看看公司的長期表現是否與基礎業務的進展一致。

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

不可否認,市場有時是有效的,但價格並不總是能反映潛在的業務表現。研究市場情緒如何隨着時間的推移而變化的一種方法是研究公司股價與其每股收益(EPS)之間的相互作用。

During five years of share price growth, Intuitive Surgical achieved compound earnings per share (EPS) growth of 9.1% per year. This EPS growth is slower than the share price growth of 17% per year, over the same period. This suggests that market participants hold the company in higher regard, these days. And that's hardly shocking given the track record of growth. This optimism is visible in its fairly high P/E ratio of 75.82.

在五年的股價增長中,Intuitive Surgical實現了每年9.1%的複合每股收益(EPS)增長。每股收益的增長低於同期每年17%的股價增長。這表明,如今,市場參與者對公司的重視程度更高。考慮到增長的記錄,這並不令人震驚。這種樂觀情緒體現在其相當高的市盈率75.82中。

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

你可以在下面看到 EPS 是如何隨着時間的推移而變化的(點擊圖片發現確切的值)。

earnings-per-share-growth
NasdaqGS:ISRG Earnings Per Share Growth February 9th 2024
納斯達克GS:ISRG每股收益增長 2024年2月9日

We know that Intuitive Surgical has improved its bottom line lately, but is it going to grow revenue? This free report showing analyst revenue forecasts should help you figure out if the EPS growth can be sustained.

我們知道Intuitive Surgical最近提高了利潤,但它會增加收入嗎?這份顯示分析師收入預測的免費報告應幫助您弄清楚每股收益的增長是否可以持續。

A Different Perspective

不同的視角

It's nice to see that Intuitive Surgical shareholders have received a total shareholder return of 58% over the last year. That gain is better than the annual TSR over five years, which is 17%. Therefore it seems like sentiment around the company has been positive lately. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. Is Intuitive Surgical cheap compared to other companies? These 3 valuation measures might help you decide.

很高興看到Intuitive Surgical的股東在過去一年中獲得了58%的總股東回報率。這一增幅好於五年內的年度股東總回報率,即17%。因此,最近公司周圍的情緒似乎一直很樂觀。在最好的情況下,這可能暗示着一些真正的業務勢頭,這意味着現在可能是深入研究的好時機。與其他公司相比,Intuitive Surgical 便宜嗎?這3種估值指標可能會幫助您做出決定。

Of course Intuitive Surgical may not be the best stock to buy. So you may wish to see this free collection of growth stocks.

當然,Intuitive Surgical可能不是最好的買入股票。因此,您可能希望看到這批免費的成長股。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

請注意,本文引用的市場回報反映了目前在美國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論